ERLOTINIB Pharmacologic Class Indexing
- Class set ID
- 4191e0f2-c3b8-4398-8a9a-7d6263b96174
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| Erlotinib Tablets | Zydus Lifesciences Limited | 20241128 | 3 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit V | 20240626 | 1 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Alembic Pharmaceuticals Limited | 20240610 | 3 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20231005 | 3 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 20230217 | 4 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Aurobindo Pharma Limited | EUGIA Pharma Specialities Limited | 20220606 | 1 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Teva Pharmaceuticals USA, Inc. | 20210317 | 7 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED | 20191203 | 1 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 20191106 | 3 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Armas Pharmaceuticals Inc. | 20191025 | 1 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Armas Pharmaceuticals Inc. | 20191025 | 1 |
| These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | Armas Pharmaceuticals Inc. | 20191025 | 1 |
| These highlights do not include all the information needed to use TARCEVA safely and effectively. See full prescribing information for TARCEVA. TARCEVA (erlotinib hydrochloride) tablet for oral use Initial U.S. Approval: 2004 | Physicians Total Care, Inc. | 20120105 | 1 |